A nice find by rndtbl over on Investor Village.
"NLRP3 inhibitors stoke anti-inflammatory ambitions."
In addition, here is a review on the NLRP3 inflammasome: "Targeting the NLRP3 inflammasome in inflammatory diseases."
Apabetalone has potent anti-inflammatory effects, many of which are consistent with cooling off of the NLRP3 cascade (see EAS 2019 poster and Vascular Discovery 2019 poster). Apabetalone SMASH inflammation!
BearDownAZ